Tronox Reports Third Quarter 2018 Financial Results
Nov 5, 2018 - Press ReleasesThird Quarter Highlights:
- Results demonstrate benefits of vertical integration with solid performance realized across the board in pigment, feedstock and co-products and all assets in full operation
- Revenue of
$456 million up 5 percent versus prior year driven primarily by higher pigment and zircon selling prices - Income from operations of
$53 million up 13 percent versus prior year; adjusted EBITDA of$128 million up 8 percent versus prior year (Non-GAAP) - GAAP diluted EPS of
$0.05 ; adjusted diluted EPS of$0.17 (Non-GAAP) - Operating cash flow of
$112 million ; free cash flow of$84 million (1) - TiO2 income from operations of
$80 million up 7 percent versus prior year; TiO2 adjusted EBITDA of$150 million up 10 percent and TiO2 adjusted EBITDA margin of 33 percent up nearly 200 basis points versus prior year (Non-GAAP) - TiO2 operating cash flow of
$148 million ; TiO2 free cash flow of$120 million (1)
Cristal TiO2 Acquisition:
Tronox continues discussions regarding potential divestiture of Cristal’sAshtabula, Ohio TiO2 facility to enable completion of Cristal acquisition
1) |
Free cash flow equals cash flow provided by (used in) operating activities less capital expenditures (Non-GAAP) |
In zircon, we continued to see favorable market conditions as a result of a tight global supply-demand balance and benefited from higher selling prices in the quarter, which more than offset lower sales volumes due to shipment timing. Demand for our pig iron products remains strong, especially for foundry grade material. The market for high-grade feedstock remains tight as a result of industry supply disruptions in the first half 2018 and declining production at other industry producers’ existing operations. As a vertically integrated producer in a rising high-grade feedstock price environment, we expect to derive significant and differentiating benefits relative to non-integrated pigment producers.”
Quinn continued, “We continue to progress toward closing the Cristal TiO2 acquisition. During the quarter, we received final approval from the European Commission to close the Cristal acquisition conditioned upon divesting our 8120 paper-laminate product grade to Venator Materials PLC. Consummation of this divestiture will occur following approval of the Cristal acquisition by U.S. regulatory authorities. We continue discussions with the
Third Quarter 2018
Tronox TiO2
TiO2 revenue of
Titanium feedstock and co-products sales of
Compared sequentially, TiO2 revenue of
Titanium feedstock and co-products sales of
TiO2 adjusted EBITDA of
Consolidated
Selling, general and administrative expenses were
Webcast Conference Call
Internet Broadcast: tronox.com
Dial-in Telephone Numbers:
U.S. /
International: +1.224.633.1393
Conference ID: 2648037
Conference Call Presentation Slides will be used during the conference call and are available on our website: tronox.com
Conference Call Replay: Available via the internet and telephone beginning on
Internet Replay:tronox.com
U.S. /
International: +1.404.537.3406
Conference ID: 2648037
Upcoming Conferences and Investor Meetings
During the fourth quarter 2018 a member of management is scheduled to present at the following conferences and hold investor meetings in the following cities:
Citi Basic Materials Conference ,New York ,November 27, 2018 - Investor meetings in
Chicago andToronto ,November 28 and 29, 2018 - Investor meetings in
San Francisco andLos Angeles ,December 4 and 5, 2018 Bank of America Merrill Lynch Leveraged Finance Conference ,Boca Raton, FL ,December 4 and 5, 2018
Accompanying conference and meeting materials will be available at http://investor.tronox.com
About
Tronox Limited is a vertically integrated mining and inorganic chemical business. The Company mines and processes titanium ore, zircon and other minerals, and manufactures titanium dioxide pigments that add brightness and durability to paints, plastics, paper, and other everyday products. For more information, visit tronox.com.
Forward Looking Statements
Statements in this release that are not historical are forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements, which are subject to known and unknown risks, uncertainties and assumptions about us, may include projections of our future financial performance based on our growth strategies and anticipated trends in our business. These statements are only predictions based on our current expectations and projections about future events. There are important factors that could cause our actual results, level of activity, performance or achievements to differ materially from the results, level of activity, performance or achievements expressed or implied by the forward-looking statements. These and other risk factors are discussed in the company’s filings with the
Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for our management to predict all risks and uncertainties, nor can management assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Although we believe the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance or achievements. Neither we nor any other person assumes responsibility for the accuracy or completeness of any of these forward-looking statements. You should not rely upon forward-looking statements as predictions of future events. Unless otherwise required by applicable laws, we undertake no obligation to update or revise any forward-looking statements, whether because of new information or future developments.
Use of Non-U.S. GAAP Financial Information
To provide investors and others with additional information regarding
Management believes these non-U.S. GAAP financial measures:
Reflect Tronox Limited’s ongoing business in a manner that allows for meaningful period-to-period comparison and analysis of trends in its business, as they exclude income and expense that are not reflective of ongoing operating results;- Provide useful information to investors and others in understanding and evaluating
Tronox Limited’s operating results and future prospects; - Provide additional view of the operating performance of the company by adding interest expenses, taxes, depreciation, depletion and amortization to the net income. Further adjustments due to gain (loss) on extinguishment of debt and stock-based compensation charges are made to exclude items that are either non-cash or unusual in nature;
- Assist investors to assess the company’s compliance with financial covenants under its debt instruments;
- Adjusted EBITDA is one of the primary measures management uses for planning and budgeting processes and to monitor and evaluate financial and operating results. Adjusted EBITDA is not a recognized term under U.S. GAAP and does not purport to be an alternative to measures of our financial performance as determined in accordance with U.S. GAAP, such as net income (loss). Because other companies may calculate EBITDA and Adjusted EBITDA differently than
Tronox , EBITDA may not be, and Adjusted EBITDA as presented in this release is not, comparable to similarly titled measures reported by other companies, and - We believe that the non-U.S. GAAP financial measure “Adjusted net income (loss) attributable to
Tronox Limited ” and its presentation on a per share basis provide useful information about our operating results to investors and securities analysts. We also believe that excluding the effects of these items from operating results allows management and investors to compare more easily the financial performance of our underlying businesses from period to period.
Media Contact:
Investor Contact:
TRONOX LIMITED |
||||||||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (U.S. GAAP) |
||||||||
(UNAUDITED) |
||||||||
(Millions of U.S. dollars, except share and per share data) |
||||||||
Three months Ended |
Nine Months Ended |
|||||||
2018 |
2017 (1) |
2018 |
2017 |
|||||
Net sales |
$ 456 |
$ 435 |
$ 1,390 |
$ 1,234 |
||||
Cost of goods sold |
335 |
329 |
1,010 |
970 |
||||
Gross profit |
121 |
106 |
380 |
264 |
||||
Selling, general, and administrative expenses |
(62) |
(59) |
(217) |
(184) |
||||
Restructuring |
– |
– |
– |
1 |
||||
Impairment loss |
(6) |
– |
(31) |
– |
||||
Income from operations |
53 |
47 |
132 |
81 |
||||
Interest expense |
(47) |
(47) |
(144) |
(140) |
||||
Interest income |
8 |
3 |
23 |
5 |
||||
Loss on extinguishment of debt |
– |
(28) |
(30) |
(28) |
||||
Other income (expense), net |
7 |
8 |
27 |
(3) |
||||
Income (loss) from continuing operations before income taxes |
21 |
(17) |
8 |
(85) |
||||
Income tax benefit (provision) |
(6) |
(11) |
16 |
(10) |
||||
Net income (loss) from continuing operations |
15 |
(28) |
24 |
(95) |
||||
Loss from discontinued operations, net of tax |
– |
(213) |
– |
(179) |
||||
Net income (loss) |
15 |
(241) |
24 |
(274) |
||||
Net income attributable to noncontrolling interest |
9 |
6 |
26 |
11 |
||||
Net income (loss) attributable to Tronox Limited |
$ 6 |
$ (247) |
$ (2) |
$ (285) |
||||
Net income (loss) per share, basic: |
||||||||
Continuing operations |
$ 0.05 |
$ (0.28) |
$ (0.01) |
$ (0.89) |
||||
Discontinued operations |
$ – |
$ (1.79) |
$ – |
$ (1.51) |
||||
Net income (loss) per share, basic |
$ 0.05 |
$ (2.07) |
$ (0.01) |
$ (2.40) |
||||
Net income (loss) per share, diluted: |
||||||||
Continuing operations |
$ 0.05 |
$ (0.28) |
$ (0.01) |
$ (0.89) |
||||
Discontinued operations |
$ – |
$ (1.79) |
$ – |
$ (1.51) |
||||
Net income (loss) per share, diluted |
$ 0.05 |
$ (2.07) |
$ (0.01) |
$ (2.40) |
||||
Weighted average shares outstanding, basic (in thousands) |
123,121 |
119,405 |
122,850 |
118,908 |
||||
Weighted average shares outstanding, diluted (in thousands) |
126,302 |
119,405 |
122,850 |
118,908 |
||||
Other Operating Data: |
||||||||
Capital expenditures |
$ 28 |
$ 23 |
$ 83 |
$ 63 |
||||
Depreciation, depletion and amortization expense |
$ 48 |
$ 45 |
$ 145 |
$ 136 |
(1) During the third quarter of 2017, we completed the sale of our wholly owned subsidiary, Tronox Alkali Corporation (“Alkali”), to Genesis Energy, L.P. As part of the calculation of the loss on the sale, during the third quarter of 2017 we reclassified $5 million of Alkali transactional expenses that we had incurred in the six months ended June 30, 2017 from continuing operations and included such amounts in the loss on sale calculation within the results of discontinued operations. Although the Condensed Consolidated Statement of Operations for the nine months ended September 30, 2017 is not impacted, when the results were restated in the third quarter of 2017 to present Alkali as discontinued operations for the previous periods, the $5 million in transactional expenses should have been included in the results of discontinued operations in the periods incurred rather than reclassified into discontinued operations upon the sale in the third quarter. Due to this revision, the results of our third quarter of 2017 have been adjusted as follows: ⢠Income from operations decreased from a $52 million to $47 million; |
TRONOX LIMITED |
|||||||
RECONCILIATION OF NON-U.S. GAAP FINANCIAL MEASURES |
|||||||
(UNAUDITED) |
|||||||
(Millions of U.S. dollars, except share and per share data) |
|||||||
RECONCILIATION OF NET INCOME (LOSS) |
|||||||
ATTRIBUTABLE TO TRONOX LIMITED (U.S. GAAP) |
|||||||
TO ADJUSTED NET INCOME (LOSS) FROM CONTINUING OPERATIONS |
|||||||
ATTRIBUTABLE TO TRONOX LIMITED (NON-U.S. GAAP) |
|||||||
Three Months Ended |
Nine Months Ended |
||||||
2018 |
2017 |
2018 |
2017 |
||||
Net income (loss) attributable to Tronox Limited (U.S. GAAP) |
$ 6 |
$ (247) |
$ (2) |
$ (285) |
|||
Loss from discontinued operations, net of tax (U.S. GAAP) |
– |
(213) |
– |
(179) |
|||
Net income (loss) from continuing operations attributable to Tronox Limited |
$ 6 |
$ (34) |
$ (2) |
$ (106) |
|||
Impairment loss (a) |
6 |
– |
31 |
– |
|||
Transaction costs (b) |
12 |
13 |
59 |
33 |
|||
Restructuring (c) |
– |
– |
– |
(1) |
|||
Tax valuation allowance reversal (d) |
– |
– |
(48) |
– |
|||
Share-based compensation modification (e) |
– |
– |
(6) |
– |
|||
Settlement gain (f) |
(3) |
– |
(3) |
– |
|||
Loss on extinguishment of debt (g) |
– |
28 |
30 |
28 |
|||
Adjusted net income (loss) from continuing operations attributable to Tronox Limited (non-U.S. GAAP) (h) |
$ 21 |
$ 7 |
$ 61 |
$ (46) |
|||
Diluted net income (loss) per share from continuing operations (U.S. GAAP) |
$ 0.05 |
$ (0.28) |
$ (0.01) |
$ (0.89) |
|||
Impairment loss, per share |
0.05 |
– |
0.24 |
– |
|||
Transaction costs, per share |
0.09 |
0.11 |
0.47 |
0.28 |
|||
Restructuring, per share |
– |
– |
– |
(0.02) |
|||
Tax valuation allowance reversal |
– |
– |
(0.38) |
– |
|||
Share-based compensation modification |
– |
– |
(0.05) |
– |
|||
Settlement gain |
(0.02) |
– |
(0.02) |
– |
|||
Loss on debt extinguishment, per share |
– |
0.23 |
0.24 |
0.24 |
|||
Diluted adjusted net income (loss) from continuing operations per share attributable to Tronox Limited (non-U.S. GAAP) |
$ 0.17 |
$ 0.06 |
$ 0.49 |
$ (0.39) |
|||
Weighted average shares outstanding, diluted (in thousands) |
126,302 |
124,519 |
125,871 |
118,908 |
(a) Represents a pre-tax charge for the impairment and expected loss on sale of the assets of our Tronox Electrolytic Operations which was recorded in “Impairment loss” in the unaudited Condensed Consolidated Statements of Operations. |
(b) Represents transaction costs primarily associated with the Cristal Transaction which were recorded in “Selling, general and administrative expenses” in the unaudited Condensed Consolidated Statements of Operations. |
(c) Represents the reversal of restructuring expense pursuant to the settlement of claims previously filed relating to a prior restructure which was recorded in “Restructuring” in the unaudited Condensed Consolidated Statements of Operations. |
(d) Represents the reversal of the tax valuation allowance attributable to our operating subsidiary in the Netherlands. |
(e) Represents the reversal of previously recorded expense related to the modification of the Integration Incentive Award. |
(f) Represents settlement gain related to the U.S. postretirement medical plan. |
(g) Represents debt extinguishment costs of $30 million including a call premium of $22 million associated with the issuance of the 2026 Senior Notes and redemption of our Senior Notes due 2022. |
(h) No income tax impact given full valuation allowance. |
TRONOX LIMITED |
|||||
CONDENSED CONSOLIDATED BALANCE SHEETS |
|||||
(UNAUDITED) |
|||||
(Millions of U.S. dollars, except share and per share data) |
|||||
September 30, |
December 31 |
||||
2018 |
2017 |
||||
ASSETS |
|||||
Current Assets |
|||||
Cash and cash equivalents |
$ 1,077 |
$ 1,116 |
|||
Restricted cash |
659 |
653 |
|||
Accounts receivable, net of allowance for doubtful accounts |
326 |
329 |
|||
Inventories, net |
475 |
473 |
|||
Prepaid and other assets |
59 |
60 |
|||
Income taxes receivable |
8 |
8 |
|||
Total current assets |
2,604 |
2,639 |
|||
Noncurrent Assets |
|||||
Property, plant and equipment, net |
1,014 |
1,115 |
|||
Mineral leaseholds, net |
809 |
885 |
|||
Intangible assets, net |
182 |
198 |
|||
Inventories, net |
– |
3 |
|||
Deferred tax assets |
43 |
1 |
|||
Other long-term assets |
62 |
23 |
|||
Total assets |
$ 4,714 |
$ 4,864 |
|||
LIABILITIES AND EQUITY |
|||||
Current Liabilities |
|||||
Accounts payable |
$ 155 |
$ 165 |
|||
Accrued liabilities |
154 |
163 |
|||
Long-term debt due within one year |
22 |
22 |
|||
Income taxes payable |
15 |
3 |
|||
Total current liabilities |
346 |
353 |
|||
Noncurrent Liabilities |
|||||
Long-term debt, net |
3,143 |
3,125 |
|||
Pension and postretirement healthcare benefits |
91 |
103 |
|||
Asset retirement obligations |
75 |
79 |
|||
Long-term deferred tax liabilities |
162 |
171 |
|||
Other long-term liabilities |
18 |
18 |
|||
Total liabilities |
3,835 |
3,849 |
|||
Commitments and Contingencies |
|||||
Shareholders’ Equity |
|||||
Tronox Limited Class A ordinary shares, par value $0.01 â 94,282,967 shares issued and 94,201,511 shares outstanding at September 30, 2018 and 92,717,935 shares issued and 92,541,463 shares outstanding at December 31, 2017 |
1 |
1 |
|||
Tronox Limited Class B ordinary shares, par value $0.01 â 28,729,280 shares issued and outstanding at September 30, 2018 and December 31, 2017. |
– |
– |
|||
Capital in excess of par value |
1,574 |
1,558 |
|||
Accumulated deficit |
(346) |
(327) |
|||
Accumulated other comprehensive loss |
(522) |
(403) |
|||
Total Tronox Limited shareholders’ equity |
707 |
829 |
|||
Noncontrolling interest |
172 |
186 |
|||
Total equity |
879 |
1,015 |
|||
Total liabilities and equity |
$ 4,714 |
$ 4,864 |
TRONOX LIMITED |
|||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS |
|||
(UNAUDITED) |
|||
(Millions of U.S. dollars) |
|||
Nine Months Ended |
|||
2018 |
2017 |
||
Cash Flows from Operating Activities: |
|||
Net income (loss) |
$ 24 |
$ (274) |
|
Loss from discontinued operations, net of tax |
– |
(179) |
|
Net income (loss) from continuing operations |
$ 24 |
$ (95) |
|
Adjustments to reconcile net income (loss) from continuing operations to net cash provided by operating activities, continuing operations: |
|||
Depreciation, depletion and amortization |
145 |
136 |
|
Deferred income taxes |
(29) |
8 |
|
Share-based compensation expense |
16 |
26 |
|
Amortization of deferred debt issuance costs and discount on debt |
9 |
9 |
|
Pension and postretirement healthcare benefit expense |
2 |
2 |
|
Loss on debt extinguishment |
30 |
28 |
|
Impairment loss |
31 |
– |
|
Other non-cash affecting net loss |
(1) |
19 |
|
Contributions to employee pension and postretirement plans |
(14) |
(18) |
|
Changes in assets and liabilities: |
|||
Increase in accounts receivable, net |
(20) |
(29) |
|
(Increase) decrease in inventories, net |
(38) |
46 |
|
Increase in prepaid and other assets |
(1) |
(16) |
|
Decrease in accounts payable and accrued liabilities |
(15) |
(27) |
|
Increase in income taxes payable |
12 |
– |
|
Other,net |
(8) |
5 |
|
Cash provided by operating activities, continuing operations |
143 |
94 |
|
Cash Flows from Investing Activities: |
|||
Capital expenditures |
(83) |
(63) |
|
Proceeds from the sale of business |
1 |
1,325 |
|
Loans |
(39) |
– |
|
Cash used in investing activities, continuing operations |
(121) |
1,262 |
|
Cash Flows from Financing Activities: |
|||
Repayments of long-term debt |
(600) |
(2,342) |
|
Repayments of short-term debt |
– |
(150) |
|
Proceeds from long-term debt |
615 |
2,589 |
|
Call premium paid |
(22) |
(14) |
|
Debt issuance costs |
(10) |
(36) |
|
Proceeds from the exercise of options and warrants |
6 |
1 |
|
Dividends paid |
(17) |
(17) |
|
Restricted stock and performance-based shares settled in cash for withholding taxes |
(6) |
(11) |
|
Cash used in financing activities, continuing operations |
(34) |
20 |
|
Discontinued Operations: |
|||
Cash provided by operating activities |
– |
107 |
|
Cash used in investing activities |
– |
(25) |
|
Net cash flows provided by discontinued operations |
– |
82 |
|
Effects of exchange rate changes on cash, cash equivalents and restricted cash |
(21) |
2 |
|
Net (decrease) increase in cash and cash equivalents |
(33) |
1,460 |
|
Cash, cash equivalents and restricted cash at beginning of period |
1,769 |
251 |
|
Cash, cash equivalents and restricted cash at end of period, continuing operations |
$1,736 |
$1,711 |
TRONOX LIMITED |
||||||||
SEGMENT INFORMATION |
||||||||
RECONCILIATION OF NET INCOME (LOSS) TO EBITDA AND ADJUSTED EBITDA (NON-U.S. GAAP) |
||||||||
(UNAUDITED) |
||||||||
(Millions of U.S. dollars) |
||||||||
Three Months Ended |
Nine Months Ended |
|||||||
2018 |
2017 |
2018 |
2017 |
|||||
Net income (loss) (U.S. GAAP) |
$ 15 |
$(241) |
$ 24 |
$(274) |
||||
Income from discontinued operations, net of tax (U.S. GAAP) |
– |
(213) |
– |
(179) |
||||
Net income (loss) from continuing operations (U.S. GAAP) |
15 |
(28) |
24 |
(95) |
||||
Interest expense |
47 |
47 |
144 |
140 |
||||
Interest income |
(8) |
(3) |
(23) |
(5) |
||||
Income tax provision (benefit) |
6 |
11 |
(16) |
10 |
||||
Depreciation, depletion and amortization expense |
48 |
45 |
145 |
136 |
||||
EBITDA (non-U.S. GAAP) |
108 |
72 |
274 |
186 |
||||
Impairment loss (a) |
6 |
– |
31 |
– |
||||
Share-based compensation (b) |
7 |
5 |
16 |
26 |
||||
Transaction costs (c) |
12 |
13 |
59 |
33 |
||||
Restructuring (d) |
– |
– |
– |
(1) |
||||
Loss on extinguishment of debt (e) |
– |
28 |
30 |
28 |
||||
Foreign currency remeasurement (f) |
(4) |
(5) |
(28) |
1 |
||||
Settlement gain (g) |
(3) |
(3) |
||||||
Other items (h) |
2 |
5 |
9 |
12 |
||||
Adjusted EBITDA (non-U.S. GAAP) |
$128 |
$ 118 |
$388 |
$ 285 |
(a) |
Represents a pre-tax charge for the impairment and expected loss on sale of the assets of our Tronox Electrolytic Operations which was recorded in “Impairment loss” in the unaudited Condensed Consolidated Statements of Operations. |
|||||||
(b) |
Represents non-cash share-based compensation. |
|||||||
(c) |
Represents transaction costs primarily associated with the Cristal Transaction which were recorded in “Selling, general and administrative expenses” in the unaudited Condensed Consolidated Statements of Operations. |
|||||||
(d) |
Represents the reversal of restructuring expense pursuant to the settlement of claims previously filed relating to a prior restructure which was recorded in “Restructuring” in the unaudited Condensed Consolidated Statements of Operations. |
|||||||
(e) |
2018 amounts represent debt extinguishment costs of $30 million including a call premium of $22 million associated with the issuance of the 2026 Senior Notes and redemption of our Senior Notes due 2022. 2017 amounts represent debt extinguishment costs associated with the repayment of our Prior Term Loan Facility, termination of our UBS revolver and the redemption of our Senior Notes due 2020. |
|||||||
(f) |
Represents foreign currency remeasurement comprised of all unrealized gains and losses as well as realized gains or losses associated with nonfunctional currency intercompany receivables and payables and related derivative instruments. These amounts are included in “Other income (expense), net” in the unaudited Condensed Consolidated Statements of Operations. |
|||||||
(g) |
Represents settlement gain related to U.S. postretirement medical plan. |
|||||||
(h) |
Includes non-cash pension and postretirement costs, severance expense, accretion expense and other items included in “Selling, general and administrative expenses”, “Cost of goods sold” and “Other income (expense), net” in the unaudited Condensed Consolidated Statements of Operations. |
TRONOX LIMITED |
|||||||
SEGMENT INFORMATION |
|||||||
OPERATING INCOME AND ADJUSTED EBITDA (NON-U.S. GAAP) |
|||||||
AND |
|||||||
FREE CASH FLOW (NON-U.S. GAAP) |
|||||||
(UNAUDITED) |
|||||||
(Millions of U.S. dollars) |
|||||||
The following table reconciles income from operations: |
|||||||
Three Months Ended |
Nine Months Ended |
||||||
2018 |
2017 |
2018 |
2017 |
||||
TiO2segment |
$ 80 |
$ 75 |
$ 240 |
$ 168 |
|||
Unallocated Corporate |
(27) |
(28) |
(108) |
(87) |
|||
Income from operations (U.S. GAAP) |
$ 53 |
$ 47 |
$ 132 |
$ 81 |
|||
The following table provides Adjusted EBITDA for TiO2segment and Corporate for the periods presented: |
|||||||
Three Months Ended |
Nine Months Ended |
||||||
2018 |
2017 |
2018 |
2017 |
||||
TiO2segment |
$ 150 |
$ 136 |
$ 457 |
$ 344 |
|||
Unallocated Corporate |
(22) |
(18) |
(69) |
(59) |
|||
Adjusted EBITDA (non-U.S. GAAP) |
$ 128 |
$ 118 |
$ 388 |
$ 285 |
|||
Adjusted EBITDA as a % of Net Sales (non-U.S. GAAP) |
28% |
27% |
28% |
23% |
|||
TiO2Adjusted EBITDA as a % of Net Sales (non-U.S. GAAP) |
33% |
31% |
33% |
28% |
|||
The following table provides a reconciliation of TiO2income from operations to Adjusted EBITDA for our TiO2segment: |
|||||||
Three Months Ended |
Nine Months Ended |
||||||
2018 |
2017 |
2018 |
2017 |
||||
TiO2segment operating income (1) |
$ 80 |
$ 75 |
$ 240 |
$ 168 |
|||
Depreciation, depletion and amortization expense |
46 |
44 |
140 |
132 |
|||
Other income (expense), net |
9 |
30 |
32 |
(19) |
|||
TiO2 EBITDA (non-U.S. GAAP) |
135 |
149 |
412 |
281 |
|||
Nonrecurring and other items (1) |
15 |
(13) |
45 |
63 |
|||
TiO2Adjusted EBITDA (non-U.S. GAAP) |
$ 150 |
$ 136 |
$ 457 |
$ 344 |
(1) TiO2 segment operating income includes an allocation of costs managed by Corporate. Nonrecurring and other items added back to TiO2 EBITDA includes an add back for the allocation of costs managed by Corporate, as well as the impairment loss, foreign currency losses (gains) and share-based compensation. |
The following table reconciles Cash provided by (used in) operating activities, continuing operations, the comparable measure for segment reporting under U.S. GAAP, to free cash flow by segment for the periods presented: |
|||||||
Three Months Ended |
Nine Months Ended |
||||||
TiO2 |
Corporate |
Consolidated |
TiO2 |
Corporate |
Consolidated |
||
Cash provided by (used in) operating activities, continuing operations |
$ 148 |
$ (36) |
$ 112 |
$ 347 |
$ (204) |
$ 143 |
|
Capital expenditures |
(28) |
– |
(28) |
(82) |
(1) |
(83) |
|
Free cash flow (non-U.S. GAAP) |
$ 120 |
$ (36) |
$ 84 |
$ 265 |
$ (205) |
$ 60 |
View original content to download multimedia:http://www.prnewswire.com/news-releases/tronox-reports-third-quarter-2018-financial-results-300744250.html
SOURCE